Published in Antimicrob Agents Chemother on November 01, 1997
The genome of Burkholderia cenocepacia J2315, an epidemic pathogen of cystic fibrosis patients. J Bacteriol (2008) 2.71
IBC-1, a novel integron-associated class A beta-lactamase with extended-spectrum properties produced by an Enterobacter cloacae clinical strain. Antimicrob Agents Chemother (2000) 2.62
A novel class A extended-spectrum beta-lactamase (BES-1) in Serratia marcescens isolated in Brazil. Antimicrob Agents Chemother (2000) 1.86
Cloning of a Chryseobacterium (Flavobacterium) meningosepticum chromosomal gene (blaA(CME)) encoding an extended-spectrum class A beta-lactamase related to the Bacteroides cephalosporinases and the VEB-1 and PER beta-lactamases. Antimicrob Agents Chemother (1999) 1.70
Inactivation of the ampD gene in Pseudomonas aeruginosa leads to moderate-basal-level and hyperinducible AmpC beta-lactamase expression. Antimicrob Agents Chemother (2000) 1.53
The twin-arginine translocation pathway of Mycobacterium smegmatis is functional and required for the export of mycobacterial beta-lactamases. J Bacteriol (2005) 1.42
Assessment of three Resistance-Nodulation-Cell Division drug efflux transporters of Burkholderia cenocepacia in intrinsic antibiotic resistance. BMC Microbiol (2009) 1.30
Biochemical-genetic analysis and distribution of FAR-1, a class A beta-lactamase from Nocardia farcinica. Antimicrob Agents Chemother (1999) 1.28
Efflux pump genes of the resistance-nodulation-division family in Burkholderia cenocepacia genome. BMC Microbiol (2006) 1.26
Molecular Investigations of PenA-mediated β-lactam Resistance in Burkholderia pseudomallei. Front Microbiol (2011) 1.25
An ampD gene in Pseudomonas aeruginosa encodes a negative regulator of AmpC beta-lactamase expression. Antimicrob Agents Chemother (1998) 1.20
Salicylate induces an antibiotic efflux pump in Burkholderia cepacia complex genomovar III (B. cenocepacia). J Clin Invest (2004) 1.18
AmpD is required for regulation of expression of NmcA, a carbapenem-hydrolyzing beta-lactamase of Enterobacter cloacae. Antimicrob Agents Chemother (2001) 1.15
Induction of L1 and L2 beta-lactamases of Stenotrophomonas maltophilia. Antimicrob Agents Chemother (2007) 1.10
Cloning and expression of class A beta-lactamase gene blaA(BPS) in Burkholderia pseudomallei. Antimicrob Agents Chemother (2002) 1.06
Spontaneous and evolutionary changes in the antibiotic resistance of Burkholderia cenocepacia observed by global gene expression analysis. BMC Genomics (2011) 1.04
ampG gene of Pseudomonas aeruginosa and its role in β-lactamase expression. Antimicrob Agents Chemother (2010) 0.97
AmpN-AmpG operon is essential for expression of L1 and L2 beta-lactamases in Stenotrophomonas maltophilia. Antimicrob Agents Chemother (2010) 0.96
Naturally occurring Class A ss-lactamases from the Burkholderia cepacia complex. Antimicrob Agents Chemother (2008) 0.94
Insights into β-lactamases from Burkholderia species, two phylogenetically related yet distinct resistance determinants. J Biol Chem (2013) 0.89
Pseudomonas aeruginosa AmpR: an acute-chronic switch regulator. Pathog Dis (2015) 0.86
Constitutive expression of a chromosomal class A (BJM group 2) beta-lactamase in Xanthomonas campestris. Antimicrob Agents Chemother (2004) 0.86
Molecular and biochemical characterization of the natural chromosome-encoded class A beta-lactamase from Pseudomonas luteola. Antimicrob Agents Chemother (2009) 0.78
A Structure-Based Classification of Class A β-Lactamases, a Broadly Diverse Family of Enzymes. Clin Microbiol Rev (2016) 0.78
Antibiotic resistance in Burkholderia species. Drug Resist Updat (2016) 0.78
Structure-Function Analysis of the Transmembrane Protein AmpG from Pseudomonas aeruginosa. PLoS One (2016) 0.75
Expression and characterization of penicillin-binding proteins in Burkholderia cenocepacia. Curr Microbiol (2009) 0.75
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
Studies on transformation of Escherichia coli with plasmids. J Mol Biol (1983) 116.81
Production of single-stranded plasmid DNA. Methods Enzymol (1987) 39.38
Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Protein Eng (1997) 38.38
A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother (1995) 26.51
A standard numbering scheme for the class A beta-lactamases. Biochem J (1991) 17.44
Plasmid cloning vehicles derived from plasmids ColE1, F, R6K, and RK2. Methods Enzymol (1979) 13.61
Molecular biology of the LysR family of transcriptional regulators. Annu Rev Microbiol (1993) 10.30
Kanamycin-resistant vectors that are analogues of plasmids pUC8, pUC9, pEMBL8 and pEMBL9. Gene (1986) 7.97
The active-site-serine penicillin-recognizing enzymes as members of the Streptomyces R61 DD-peptidase family. Biochem J (1988) 7.51
Chromosomal beta-lactamase of Klebsiella oxytoca, a new class A enzyme that hydrolyzes broad-spectrum beta-lactam antibiotics. Antimicrob Agents Chemother (1989) 5.98
Sequences of beta-lactamase genes encoding CTX-M-1 (MEN-1) and CTX-M-2 and relationship of their amino acid sequences with those of other beta-lactamases. Antimicrob Agents Chemother (1996) 5.36
Close amino acid sequence relationship between the new plasmid-mediated extended-spectrum beta-lactamase MEN-1 and chromosomally encoded enzymes of Klebsiella oxytoca. Biochim Biophys Acta (1992) 5.09
Comparison of the sequences of class A beta-lactamases and of the secondary structure elements of penicillin-recognizing proteins. Antimicrob Agents Chemother (1991) 5.05
Taxonomy of the aerobic pseudomonads: Pseudomonas cepacia, P. marginata, P. alliicola and P. caryophylli. J Gen Microbiol (1970) 4.58
Inducible cephalosporinase production in clinical isolates of Enterobacter cloacae is controlled by a regulatory gene that has been deleted from Escherichia coli. EMBO J (1986) 4.15
Regulatory components in Citrobacter freundii ampC beta-lactamase induction. Proc Natl Acad Sci U S A (1985) 3.93
Sequence of the Citrobacter freundii OS60 chromosomal ampC beta-lactamase gene. Eur J Biochem (1986) 3.93
Crystal structure of Escherichia coli TEM1 beta-lactamase at 1.8 A resolution. Proteins (1993) 3.70
Sequence and comparative analysis of three Enterobacter cloacae ampC beta-lactamase genes and their products. Biochem J (1988) 3.66
Characterization of IMI-1 beta-lactamase, a class A carbapenem-hydrolyzing enzyme from Enterobacter cloacae. Antimicrob Agents Chemother (1996) 3.44
Cloning and nucleotide sequencing of the gene encoding the beta-lactamase from Citrobacter diversus. FEMS Microbiol Lett (1991) 3.24
Cloning, sequencing and analysis of the structural gene and regulatory region of the Pseudomonas aeruginosa chromosomal ampC beta-lactamase. Biochem J (1990) 3.20
Binding of the Citrobacter freundii AmpR regulator to a single DNA site provides both autoregulation and activation of the inducible ampC beta-lactamase gene. J Bacteriol (1989) 2.95
Analysis of a carbapenem-hydrolyzing class A beta-lactamase from Enterobacter cloacae and of its LysR-type regulatory protein. Proc Natl Acad Sci U S A (1994) 2.92
Conserved motifs in a divergent nod box of Azorhizobium caulinodans ORS571 reveal a common structure in promoters regulated by LysR-type proteins. Proc Natl Acad Sci U S A (1992) 2.67
Cefotaxime-hydrolysing activity of the beta-lactamase of Klebsiella oxytoca D488 could be related to a threonine residue at position 140. FEMS Microbiol Lett (1991) 2.53
The phototrophic bacterium Rhodopseudomonas capsulata sp108 encodes an indigenous class A beta-lactamase. Biochem J (1989) 2.44
Regulation of diaminopimelate decarboxylase synthesis in Escherichia coli. III. Nucleotide sequence and regulation of the lysR gene. J Mol Biol (1983) 2.40
Nucleotide sequence of a new class A beta-lactamase gene from the chromosome of Yersinia enterocolitica: implications for the evolution of class A beta-lactamases. Mol Gen Genet (1991) 2.35
Role of the conserved amino acids of the 'SDN' loop (Ser130, Asp131 and Asn132) in a class A beta-lactamase studied by site-directed mutagenesis. Biochem J (1990) 2.27
Chromosomally encoded cephalosporin-hydrolyzing beta-lactamase of Proteus vulgaris RO104 belongs to Ambler's class A. Biochim Biophys Acta (1994) 2.07
Elucidation of the role of arginine-244 in the turnover processes of class A beta-lactamases. Biochemistry (1992) 1.96
Resistance of Escherichia coli to penicillins: fine-structure mapping and dominance of chromosomal beta-lactamase mutations. J Bacteriol (1977) 1.96
Characterization of an LysR family protein, SmeR from Serratia marcescens S6, its effect on expression of the carbapenem-hydrolyzing beta-lactamase Sme-1, and comparison of this regulator with other beta-lactamase regulators. Antimicrob Agents Chemother (1995) 1.67
Regulation of diaminopimelate decarboxylase synthesis in Escherichia coli. I. Identification of a lysR gene encoding an activator of the lysA gene. J Mol Biol (1983) 1.66
Ceftazidime alone and in combination in patients with cystic fibrosis: lack of efficacy in treatment of severe respiratory infections caused by Pseudomonas cepacia. J Antimicrob Chemother (1983) 1.60
beta-Lactamase induction in gram-negative bacteria is intimately linked to peptidoglycan recycling. Microb Drug Resist (1995) 1.56
A structure-based analysis of the inhibition of class A beta-lactamases by sulbactam. Biochemistry (1994) 1.47
Investigation of the Pseudomonas aeruginosa ampR gene and its role at the chromosomal ampC beta-lactamase promoter. FEMS Microbiol Lett (1993) 1.34
Stability of wild-type and mutant RTEM-1 beta-lactamases: effect of the disulfide bond. Proteins (1987) 1.28
Isolation and characterization of a penicillinase from Pseudomonas cepacia 249. Antimicrob Agents Chemother (1988) 1.28
A common system controls the induction of very different genes. The class-A beta-lactamase of Proteus vulgaris and the enterobacterial class-C beta-lactamase. Eur J Biochem (1994) 1.27
Nucleotide sequence of the ampC-ampR region from the chromosome of Yersinia enterocolitica. Antimicrob Agents Chemother (1992) 1.26
TEM1 beta-lactamase structure solved by molecular replacement and refined structure of the S235A mutant. Acta Crystallogr D Biol Crystallogr (1995) 1.20
The structures and catalytic mechanisms of active-site serine beta-lactamases. Biotechnol Genet Eng Rev (1994) 1.09
Nucleotide sequence and transcriptional analysis of activator-regulator proteins for beta-lactamase in Streptomyces cacaoi. J Bacteriol (1992) 1.08
Inducible expression of the chromosomal cdiA from Citrobacter diversus NF85, encoding an ambler class A beta-lactamase, is under similar genetic control to the chromosomal ampC, encoding an ambler class C enzyme, from Citrobacter freundii OS60. Microb Drug Resist (1995) 1.04
The Pseudomonas cepacia 249 chromosomal penicillinase is a member of the AmpC family of chromosomal beta-lactamases. Antimicrob Agents Chemother (1993) 1.04
Decreased baseline beta-lactamase production and inducibility associated with increased piperacillin susceptibility of Pseudomonas cepacia isolated from children with cystic fibrosis. Pediatr Res (1986) 1.00
Sequence and molecular characterization of the ROB-1 beta-lactamase gene from Pasteurella haemolytica. Antimicrob Agents Chemother (1991) 0.98
Induction of a Streptomyces cacaoi beta-lactamase gene cloned in S. lividans. Mol Gen Genet (1992) 0.81
Analysis of the penA gene of Pseudomonas cepacia 249. Antimicrob Agents Chemother (1994) 0.80
Contribution of specific Pseudomonas aeruginosa virulence factors to pathogenesis of pneumonia in a neonatal mouse model of infection. Infect Immun (1996) 4.08
Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8. J Clin Invest (1995) 3.78
Defective acidification of intracellular organelles in cystic fibrosis. Nature (1991) 3.66
Role of flagella in pathogenesis of Pseudomonas aeruginosa pulmonary infection. Infect Immun (1998) 3.43
Pseudomonas aeruginosa pili bind to asialoGM1 which is increased on the surface of cystic fibrosis epithelial cells. J Clin Invest (1993) 3.00
The effect of piliation and exoproduct expression on the adherence of Pseudomonas aeruginosa to respiratory epithelial monolayers. J Infect Dis (1990) 2.98
Role of Pseudomonas aeruginosa pili in acute pulmonary infection. Infect Immun (1995) 2.53
Pseudomonas aeruginosa cell-to-cell signaling is required for virulence in a model of acute pulmonary infection. Infect Immun (2000) 2.40
Activation of NF-kappaB in airway epithelial cells is dependent on CFTR trafficking and Cl- channel function. Am J Physiol Lung Cell Mol Physiol (2001) 2.36
Transcriptional activation of mucin by Pseudomonas aeruginosa lipopolysaccharide in the pathogenesis of cystic fibrosis lung disease. Proc Natl Acad Sci U S A (1997) 2.24
Antibiotic susceptibility of multiply resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis, including candidates for transplantation. Clin Infect Dis (1996) 2.23
Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells. J Clin Invest (1998) 2.05
On language and connectionism: analysis of a parallel distributed processing model of language acquisition. Cognition (1988) 2.04
Cystic fibrosis epithelial cells have a receptor for pathogenic bacteria on their apical surface. Proc Natl Acad Sci U S A (1995) 1.97
Neuromuscular disease in primary hyperparathyroidism. Ann Intern Med (1974) 1.69
Production of the Pseudomonas aeruginosa neuraminidase is increased under hyperosmolar conditions and is regulated by genes involved in alginate expression. J Clin Invest (1992) 1.58
Inactivation of the ampD gene in Pseudomonas aeruginosa leads to moderate-basal-level and hyperinducible AmpC beta-lactamase expression. Antimicrob Agents Chemother (2000) 1.53
Cystic fibrosis pathogens activate Ca2+-dependent mitogen-activated protein kinase signaling pathways in airway epithelial cells. J Biol Chem (2001) 1.49
Evidence for horizontal gene transfer in evolution of elongation factor Tu in enterococci. J Bacteriol (2000) 1.42
Binding of Pseudomonas aeruginosa to respiratory epithelial cells from patients with various mutations in the cystic fibrosis transmembrane regulator. J Pediatr (1995) 1.40
Characterization of a Tn5382-like transposon containing the vanB2 gene cluster in a Clostridium strain isolated from human faeces. J Antimicrob Chemother (2005) 1.38
Antibiotic resistance of Pseudomonas species. J Pediatr (1986) 1.36
Pseudomonas aeruginosa induction of apoptosis in respiratory epithelial cells: analysis of the effects of cystic fibrosis transmembrane conductance regulator dysfunction and bacterial virulence factors. Am J Respir Cell Mol Biol (2000) 1.35
Modulation of chromatin superstructure induced by poly(ADP-ribose) synthesis and degradation. J Biol Chem (1986) 1.30
Comparison of adherence of Pseudomonas aeruginosa to respiratory epithelial cells from cystic fibrosis patients and healthy subjects. Infect Immun (1992) 1.30
Quality of life issues for fibromyalgia patients. Arthritis Care Res (2000) 1.27
Pseudomonas cepacia adherence to respiratory epithelial cells is enhanced by Pseudomonas aeruginosa. Infect Immun (1990) 1.27
Treatment of intractable gastrointestinal manifestations of chronic granulomatous disease with cyclosporine. J Pediatr (1995) 1.23
An ampD gene in Pseudomonas aeruginosa encodes a negative regulator of AmpC beta-lactamase expression. Antimicrob Agents Chemother (1998) 1.20
High prevalence of glycopeptide resistance genes vanB, vanD, and vanG not associated with enterococci in human fecal flora. Antimicrob Agents Chemother (2005) 1.19
Fractional processing of sequential bronchoalveolar lavage to separate bronchial and alveolar samples. Am Rev Respir Dis (1990) 1.14
Overproduction of the CFTR R domain leads to increased levels of asialoGM1 and increased Pseudomonas aeruginosa binding by epithelial cells. Am J Respir Cell Mol Biol (1998) 1.13
Pediatric infective endocarditis in the modern era. J Pediatr (1993) 1.13
Modulation of chromatin structure by poly(ADP-ribosyl)ation. Biochem Cell Biol (1988) 1.05
Presence of EBV antibodies in sera from wild chimpanzees. Nature (1971) 1.04
The Pseudomonas cepacia 249 chromosomal penicillinase is a member of the AmpC family of chromosomal beta-lactamases. Antimicrob Agents Chemother (1993) 1.04
Ruminococcus gauvreauii sp. nov., a glycopeptide-resistant species isolated from a human faecal specimen. Int J Syst Evol Microbiol (2008) 1.04
Development of a real-time PCR assay for the specific detection and identification of Streptococcus pseudopneumoniae using the recA gene. Clin Microbiol Infect (2011) 0.99
Cross-reactivity of Pseudomonas aeruginosa antipilin monoclonal antibodies with heterogeneous strains of P. aeruginosa and Pseudomonas cepacia. Infect Immun (1989) 0.99
A direct comparison of the antigen-specific antibody profiles of intravenous immunoglobulins derived from US and UK donor plasma. Vox Sang (2002) 0.94
Host-bacterial interactions in the initiation of inflammation. Paediatr Respir Rev (2001) 0.94
Failure of varicella-zoster immunoglobulin in modification of severe congenital varicella. Pediatr Infect Dis (1987) 0.93
Pseudomonas cepacia in cystic fibrosis patients. Am Rev Respir Dis (1986) 0.93
Clostridium lavalense sp. nov., a glycopeptide-resistant species isolated from human faeces. Int J Syst Evol Microbiol (2009) 0.93
The effects of aerosolized dextran in a mouse model of Pseudomonas aeruginosa pulmonary infection. J Infect Dis (1999) 0.90
Poly(ADP-ribosyl)ation of chromatin: kinetics of relaxation and its effect on chromatin solubility. Can J Biochem Cell Biol (1985) 0.88
Characterization of the immune response against hepatitis C infection in recovered, and chronically infected chimpanzees. J Viral Hepat (2002) 0.88
Development of markers for cholinergic neurones in re-aggregate cultures of foetal rat whole brain in serum-containing and serum-free media: effects of triiodothyronine (T3). Br J Pharmacol (1984) 0.88
Bilateral discoid medial menisci: a case report and literature review. Arthroscopy (1993) 0.85
Sequential ADP-ribosylation pattern of nucleosomal histones. ADP-ribosylation of nucleosomal histones. Eur J Biochem (1985) 0.85
Synthesis of ( )-prostaglandin E 1 , ( )-11-deoxyprostaglandins E 1 , F 1 , and F 1 , and ( )-9-oxo-13-cis-prostenoic acid by conjugate addition of vinylcopper reagents. J Am Chem Soc (1972) 0.85
Structure-function studies of Ser-289 in the class C beta-lactamase from Enterobacter cloacae P99. Antimicrob Agents Chemother (1999) 0.84
Speed of change in pancreatic mass and in intestinal bacteriology of parenterally fed rats. Clin Sci (Lond) (1980) 0.84
Pericarditis complicating meningococcal meningitis in a 7-month-old boy. Clin Pediatr (Phila) (1994) 0.84
Hyper(ADP-ribosyl)ation of histone H1. Can J Biochem (1982) 0.83
Lactoperoxidase. New recognition of an "old" enzyme in airway defenses. Am J Respir Cell Mol Biol (2000) 0.83
Management of fever in patients with central vein catheters. Pediatr Infect Dis (1986) 0.83
The measurement of team process. Hum Factors (1995) 0.82
vanD and vanG-like gene clusters in a Ruminococcus species isolated from human bowel flora. Antimicrob Agents Chemother (2007) 0.82
Characterization of the mouse collectin gene locus. Am J Respir Cell Mol Biol (1999) 0.80
[Home treatment of psoriasis using ultraviolet B irradiation]. Ned Tijdschr Geneeskd (1994) 0.80
Incidence of diarrhea and colitis associated with clindamycin therapy. J Infect Dis (1977) 0.80
The CFTR advantage--capitalizing on a quirk of fate. Nat Med (1998) 0.78
Towards a new predictor of AIDS progression through the quantitation of HIV-1 DNA copies by PCR in HIV-infected individuals. Br J Haematol (1992) 0.77
Aggregation of Dictyostelium discoideum is dependent on myristoylation and membrane localization of the G protein alpha-subunit, G alpha 2. J Cell Biochem (1999) 0.77
Preparation of prostaglandins A2, E2 and 11-epi-E2 from their 15 acetates methyl esters using an endogenous enzyme system present in Plexaura homomalla (esper). Prostaglandins (1973) 0.76
In vitro virucidal effectiveness of a 0.12%-chlorhexidine gluconate mouthrinse. J Dent Res (1990) 0.76
Beta-lactamase activity in Shigella sonnei. Antimicrob Agents Chemother (1976) 0.75
Augmentation of pulmonary host defense against Pseudomonas by FcgammaRIIA cDNA transfer to the respiratory epithelium. J Clin Invest (1999) 0.75
Infections of the heart. Adv Pediatr Infect Dis (1989) 0.75
Effects of fat adaptation on glucose kinetics and substrate oxidation during low-intensity exercise. Equine Vet J Suppl (2002) 0.75
Hepatitis B vaccine safety monitoring in the chimpanzee: interpretation of results. J Med Primatol (1984) 0.75
A serologic study of HIV infection in Liberia. J Acquir Immune Defic Syndr (1988) 0.75
Independent divergences in the CD4 binding site and V3 loop encoded in two seroprevalent Ugandan HIV-1 clinical isolates. J Acquir Immune Defic Syndr (1993) 0.75
Comparison of conventional and automated methods of obtaining scotopic thresholds. J Opt Soc Am (1969) 0.75
Sequence of the ponA gene and characterization of the penicillin-binding protein 1A of Pseudomonas aeruginosa PAO1. Gene (1997) 0.75
[Growth disorders. Ilizarov fixator]. Soins Chir (1990) 0.75
Inhibitors of cyclic AMP phosphodiesterase. 1. Analogues of cilostamide and anagrelide. J Med Chem (1987) 0.75
Rules and connections in human language. Trends Neurosci (1988) 0.75